Cell-Based Assay Market, Size, Share, Trends, Industry Scope 2022-2027 by Kanika Sharma

Global Cell-Based Assay Market Research Report 2022-2027

About IMARC Group

Report Description

International Market Analysis Research and Consulting Group is a leading adviser on management strategy and market research worldwide. We partner with clients in all regions and industry verticals to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, chemicals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

Report Description and Highlights Report Description Global Cell-Based Assay Market Outlook 2022-2027: The latest report by IMARC Group, titled “Cell-Based Assay Market: Global Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2022-2027,” finds that the global cell-based assay market size reached US$ 18.9 Billion in 2021. Cell-based assay or cellular assay is an analytical method to determine the concentration of a substance by observing its effects on living organisms (in vivo) or tissues (in vitro). It provides a closer representation of the real-life model, which helps to verify the biological activity of drugs and determine whether the antibodies produced by the patient are neutralizing the drug. Owing to these properties, cell-based assays are widely adopted in biomedical research and drugdiscovery screening for gene activation, cell signaling, cell proliferation, antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), apoptosis, and necrosis. Request for a PDF sample of this report: https://www.imarcgroup.com/cell-based-assays-market/requestsample

Report Description and Highlights

Report Description

Global Cell-Based Assay Market Drivers/Constraints: The market is primarily driven by the growing prevalence of chronic disorders such as cancer, diabetes, and cardiovascular diseases. Nowadays, cell-based assays are widely used for screening mutagenesis in chronic myeloid leukemia. In addition, the rising adoption of cell-based assays in drug discovery represents another major growth-inducing factor. Besides this, with various technological advancements, researchers are using this technique for high throughput screening methods like toxicity studies, drug screening, and in vitro testing. This, coupled with extensive research and development (R&D) activities conducted by the leading players to formulate safer drugs, is propelling the market growth. Moreover, the introduction of 3D and label-free cell-based assays, the rising number of drug discovery companies, and huge investments in cell-based research activities are some of the other factors creating a favorable market outlook across the globe. View Report TOC, Figures and Tables: https://www.imarcgroup.com/cell-based-assays-market

Report Description and Highlights

Report Description Key Market Segmentation

The research report includes the following segments:

Breakup by Product and Services: • • • • • • • • • • •

Consumables Reagents and Media Cells and Cell Lines Probes and Labels Instruments Microplates Microplate Readers High Throughput Screening Liquid Handling Systems Services Software

Report Description and Highlights

Report Description Breakup by Technology: • • • •

Automated Handling Flow Cytometry Label-Free Detection High-Throughput Screening

Breakup by Application: • • • •

Drug Discovery Basic Research ADME Studies Predictive Toxicology

Breakup by End-User: • • •

Pharmaceutical and Biotechnology Companies Academic and Government Institutions Contract Research Organizations

Report Description and Highlights

Report Description Breakup by Region: • • • • •

North America Asia Pacific Europe Latin America Middle East and Africa

Looking forward, IMARC Group expects the market to reach US$ 31.4 Billion by 2027, exhibiting at a CAGR of 8.78% during 2022-2027.

Report Description and Highlights

Report Description Competitive Landscape: • • • • • • • • • • • • • •

Becton Dickinson and Company GE Healthcare Biopharma (Danaher Corporation) Thermo Fisher Scientific Inc Merck Group Perkinelmer Inc Charles River Laboratories Inc Lonza Group Ltd Cell Signaling Technology Inc Promega Corporation Cell Biolabs Inc Eurofins DiscoverX Corporation Bio-Rad Laboratories Inc Corning Inc F. Hoffmann-La Roche AG (Roche Holding AG)

Note: We are updating our reports, If you want the report with the latest primary and secondary data (2022-2027) including industry trends, market size and Competitive landscape, etc. Click here: https://www.imarcgroup.com/cell-based-assays-market/requestsample

Key Questions Answered in the Report

Report Description

1. What has been the historical growth rate of the global Cell-Based Assay Market? 2. What has been the impact of COVID-19 on the global Cell-Based Assay Market? 3. What are the key factors driving the global Cell-Based Assay Market? 4. What is the breakup of the global Cell-Based Assay Market based on the type? 5. What is the breakup of the global Cell-Based Assay Market based on the application? 6. What is the breakup of the global Cell-Based Assay Market based on the distribution channel? 7. What are the key regions in the global Cell-Based Assay Market? 8. Who are the key players/companies in the global Cell-Based Assay Market?

Report Description 1

Preface

2 Scope and Methodology 2.1 Objectives of the Study 2.2 Stakeholders 2.3 Data Sources 2.3.1 Primary Sources 2.3.2 Secondary Sources 2.4 Market Estimation 2.4.1 Bottom-Up Approach 2.4.2 Top-Down Approach 2.5 Forecasting Methodology

3 Executive Summary 4 Introduction 4.1 Overview 4.2 Key Industry Trends

Table of Contents

Report Description 5

Table of Contents

Global Cell-Based Assay Market Industry 5.1 5.2 5.3 5.4 5.5 5.6 5.7 5.8

Market Overview Market Performance Impact of COVID-19 Market Breakup by Product and Services Market Breakup by Technology Market Breakup by Application Market Breakup by End-User Market Breakup by Region

Click here to visit the complete table of content with list of figures and tables: https://www.imarcgroup.com/cell-based-assays-market/toc

A partial List of

We are the trusted business partners to the

Clients world's leading corporates, governments, and ourPartial ClientsList of institutions

A partial List of

We are the trusted business partners to the

of Clients leading corporates, governments, and ourPartial ClientsListworld's institutions

Report Description and Highlights

Report Description

© 2022 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

FOR MORE DETAILS Visit us at :

https://www.imarcgroup.com Stay With Us:

TELEPHONE: +1-631-791-1145 E-MAIL: sales@imarcgroup.com